MAUDE Adverse Event Report: SYMATESE EVOLYSSE SMOOTH; IMPLANT, DERMAL, FOR AESTHETIC USE

Catalog Number	EVO-SMTH-01
Medical Device Problem Code	Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes	Skin Discoloration (2074); Obstruction/Occlusion (2422)
Date of Event	04/07/2026
Type of Reportable Event	Serious Injury
Event or Problem Description
On 07-apr-2026, the hcp reported injecting 1 ml of evolysse smooth superficially into the skin around the mouth of a patient, using the provided 30-gauge needle.Immediately following the injection, the patient experienced discoloration in the left oral commissure without pain.The hcp injected the area with 7 vials of hyaluronidase, symptoms improved, and capillary refill was normal.Hcp prescribed warm compress and massage.
Additional Manufacturer Narrative
The filler was injected into the patient and is not available for return.The batch release form was reviewed and the device met all specifications prior to release.Based on the reported information, this event is consistent with a vascular occlusion which is a known serious adverse event documented in the labeling.This can occur due to unintended injection into a blood vessel or injection of a large amount of filler near a blood vessel causing compression of the blood vessel.Both occlusion and compression may result in reduced or cessation of blood supply to tissues.Intervention is required to prevent serious and permanent complications.(b)(4).
Additional Manufacturer Narrative
The filler was injected into the patient and is not available for return.The batch release form was reviewed and the device met all specifications prior to release.Based on the reported information, this event is consistent with a vascular occlusion which is a known serious adverse event documented in the labeling.This can occur due to unintended injection into a blood vessel or injection of a large amount of filler near a blood vessel causing compression of the blood vessel.Both occlusion and compression may result in reduced or cessation of blood supply to tissues.Intervention is required to prevent serious and permanent complications.Eus-(b)(4).Follow-up 1 april 23, 2026 b5: updated patient status as symptoms resolved d3: updated manufacturer's email f7: report type changed to follow-up.
Event or Problem Description
On (b)(6) 2026, the hcp reported injecting 1 ml of evolysse smooth superficially into the skin around the mouth of a patient, using the provided 30-gauge needle.Immediately following the injection, the patient experienced discoloration in the left oral commissure without pain.The hcp injected the area with 7 vials of hyaluronidase, symptoms improved, and capillary refill was normal.Hcp prescribed warm compress and massage.As of (b)(6) 2026, the patients symptoms have resolved.

• Brand Name: EVOLYSSE SMOOTH
• Common Device Name: IMPLANT, DERMAL, FOR AESTHETIC USE
• Manufacturer (Section D): SYMATESE; zi les troques; chapnost, auvergne-rhone-alpes 69630 ; FR 69630
• MDR Report Key: 24877420
• Report Number: 3015260155-2026-00008
• Device Sequence Number: 9081924
• Product Code: LMH
• UDI-Device Identifier: 03760172161301
• UDI-Public: (01)03760172161301(17)270531(10)S2252120357
• Combination Product (Y/N): N
• Initial Reporter State: OH
• Initial Reporter Country: US
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2026
• Serviced by Third Party (Y/N): N
• Reporter Type: Importer
• Initial Reporter Occupation: Nurse Practitioner
• Type of Report: Initial,Followup
• Report Date (Section B): 04/23/2026
• Report Date (Section F): 04/23/2026

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Catalogue Number: EVO-SMTH-01
• Device Lot Number: S2252120357
• Was Device Available for Evaluation?: No
• Was the Report Sent to FDA?: Yes
• Distributor Facility Aware Date: 04/10/2026
• Event Location: Other
• Date Report to Manufacturer: 04/23/2026
• Type of Report(Section G): Follow-Up
• Initial Date Received by Manufacturer: Not provided
• Supplement Date Received by Manufacturer: Not provided
• Initial Report FDA Received Date: 04/14/2026
• Supplement Report FDA Received Date: 04/23/2026
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 40 YR
• Patient Sex: Female
• Date Report Sent to FDA: 04/23/2026